These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23665994)

  • 41. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin.
    Sandvig K; van Deurs B
    Physiol Rev; 1996 Oct; 76(4):949-66. PubMed ID: 8874490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The intracellular voyage of cholera toxin: going retro.
    Lencer WI; Tsai B
    Trends Biochem Sci; 2003 Dec; 28(12):639-45. PubMed ID: 14659695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm.
    Fujinaga Y; Wolf AA; Rodighiero C; Wheeler H; Tsai B; Allen L; Jobling MG; Rapoport T; Holmes RK; Lencer WI
    Mol Biol Cell; 2003 Dec; 14(12):4783-93. PubMed ID: 13679513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxin Transport by A-B Type of Toxins in Eukaryotic Target Cells and Its Inhibition by Positively Charged Heterocyclic Molecules.
    Benz R; Barth H
    Curr Top Microbiol Immunol; 2017; 406():229-256. PubMed ID: 28674946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.
    Garred O; Dubinina E; Holm PK; Olsnes S; van Deurs B; Kozlov JV; Sandvig K
    Exp Cell Res; 1995 May; 218(1):39-49. PubMed ID: 7737376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique features in the intracellular transport of typhoid toxin revealed by a genome-wide screen.
    Chang SJ; Jin SC; Jiao X; Galán JE
    PLoS Pathog; 2019 Apr; 15(4):e1007704. PubMed ID: 30951565
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Ramasamy K; Balasubramanian S; Manickam K; Pandranki L; Taylor AB; Hart PJ; Baseman JB; Kannan TR
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362229
    [No Abstract]   [Full Text] [Related]  

  • 48. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
    Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
    Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
    Noakes KL; Teisserenc HT; Lord JM; Dunbar PR; Cerundolo V; Roberts LM
    FEBS Lett; 1999 Jun; 453(1-2):95-9. PubMed ID: 10403383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin.
    Johannes L; Tenza D; Antony C; Goud B
    J Biol Chem; 1997 Aug; 272(31):19554-61. PubMed ID: 9235960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocytosis and retrograde transport of Shiga toxin.
    Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
    Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.
    Lee MS; Cherla RP; Tesh VL
    Toxins (Basel); 2010 Jun; 2(6):1515-35. PubMed ID: 22069648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial genotoxins: The long journey to the nucleus of mammalian cells.
    Frisan T
    Biochim Biophys Acta; 2016 Mar; 1858(3):567-75. PubMed ID: 26299818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives.
    Sandvig K; van Deurs B
    EMBO J; 2000 Nov; 19(22):5943-50. PubMed ID: 11080141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Shiga-like toxins by brefeldin A.
    Donta ST; Tomicic TK; Donohue-Rolfe A
    J Infect Dis; 1995 Mar; 171(3):721-4. PubMed ID: 7876627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AB5 ADP-ribosylating toxins: comparative anatomy and physiology.
    Burnette WN
    Structure; 1994 Mar; 2(3):151-8. PubMed ID: 8069630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multivalent Inhibitors of Channel-Forming Bacterial Toxins.
    Yamini G; Nestorovich EM
    Curr Top Microbiol Immunol; 2017; 406():199-227. PubMed ID: 27469304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport.
    Mallard F; Antony C; Tenza D; Salamero J; Goud B; Johannes L
    J Cell Biol; 1998 Nov; 143(4):973-90. PubMed ID: 9817755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3.
    Yu M; Haslam DB
    Infect Immun; 2005 Apr; 73(4):2524-32. PubMed ID: 15784599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A bacterial toxin and a nonenveloped virus hijack ER-to-cytosol membrane translocation pathways to cause disease.
    He K; Ravindran MS; Tsai B
    Crit Rev Biochem Mol Biol; 2015; 50(6):477-88. PubMed ID: 26362261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.